A case of palmoplantar pustulosis induced by certolizumab pegol: New anti-TNF-alpha demonstrates the same class effect
Article
Shelling, ML, Vitiello, M, Lanuti, EL et al. (2012). A case of palmoplantar pustulosis induced by certolizumab pegol: New anti-TNF-alpha demonstrates the same class effect
. 5(8), 40-41.
Shelling, ML, Vitiello, M, Lanuti, EL et al. (2012). A case of palmoplantar pustulosis induced by certolizumab pegol: New anti-TNF-alpha demonstrates the same class effect
. 5(8), 40-41.
The development of de novo psoriasis in patients treated with tumor necrosis factor-alpha antagonists is well recognized. The authors hereby report a case of palmplantar pustular psoriasis in a patient with rheumatoid arthritis treated with etanercept. The condition responded to topical steroids but re-occurred upon treating the patient with certolizumab pegol. This strongly suggests that the development of de novo psoriasis is a class effect.
